Biotech stocks can be highly risky. In this Motley Fool Live video recorded on Sept. 8, 2021, Motley Fool contributors Keith Speights and Brian Orelli talk about two biotech stocks to buy right now that offer attractive risk-reward propositions. Keith Speights: Brian, I'm going to pitch you a softball here.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting